ICU Medical Is Maintained at Outperform by Raymond James
Raymond James Maintains ICU Medical(ICUI.US) With Buy Rating, Raises Target Price to $190
ICU Medical Analyst Ratings
Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $147
ICU Medical Analyst Ratings
ICU Medical (ICUI) Gets a Hold From Needham
KeyBanc Reaffirms Their Buy Rating on ICU Medical (ICUI)
ICU Medical Analyst Ratings
ICU Medical Analyst Ratings
Raymond James Upgrades ICU Medical to Outperform, Announces $135 Price Target
Analysts Are Bullish on These Healthcare Stocks: ICU Medical (ICUI), AbCellera Biologics (ABCL)
ICU Medical Analyst Ratings
KeyBanc Reaffirms Their Buy Rating on ICU Medical (ICUI)
ICU Medical Analyst Ratings
CL King Initiates Coverage On ICU Medical With Buy Rating, Announces Price Target of $110
ICU Medical Analyst Ratings
Keybanc Adjusts Price Target on ICU Medical to $216 From $200, Keeps Overweight Rating
Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $216
ICU Medical Analyst Ratings